A Novel Family of L-Amino Acid-Based Biodegradable Polymer-Lipid Conjugates for the Development of Long-Circulating Liposomes with Effective Drug-Targeting Capacity

Bioconjugate Chemistry

Volumn 14, Issue 6, 2003, Pages 1156-1164

  Metselaar, Josbert M ^a,d   Bruin, Peter ^a   De Boer, Leo W T ^c   De Vringer, Tom ^c   Snel, Cor ^a   Oussoren, Christien ^a   Wauben, Marca H M ^b,d   Crommelin, Daan J A ^a,d   Storm, Gert ^a,d   Hennink, Wim E ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ASTELLAS PHARMA INC   (Japan)

^d UNYPHAR   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIODEGRADABLE POLYMERS; CHOLESTEROL; DISEASES; FUNCTIONAL POLYMERS; PLASTIC COATINGS; POLYETHYLENE GLYCOLS; RATS;

BIODISTRIBUTIONS; CIRCULATION TIME; DIPALMITOYL PHOSPHATIDYLCHOLINE; DRUG-TARGETING; HYDROXYALKYLS; L ASPARAGINES; L-AMINO ACIDS; L-GLUTAMINE; LONG-CIRCULATING LIPOSOMES; SYNTHESISED;

LIPOSOMES;

ALKYL GROUP; AMINO ACID; ASPARAGINE DERIVATIVE; BIOLOGICAL MARKER; CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; GLUTAMINE; GLUTAMINE DERIVATIVE; HYDROXYL GROUP; LIPID; LIPOSOME; MACROGOL; POLYMER; POLYPEPTIDE; PREDNISOLONE DERIVATIVE; PREDNISOLONE SULFATE; UNCLASSIFIED DRUG;

ARTHRITIS; ARTICLE; BIODEGRADATION; DRUG ACTIVITY; DRUG COATING; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG TARGETING; EXPERIMENTATION; RAT STRAIN;

EID: 10744219907     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0340363     Document Type: Article

References (40)

1. Bangham, A. D., and Horne, R. W. (1964) Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electrone microscope. J. Mol. Biol. 8, 660-668.
2. (1998) Medical applications of liposomes (D. D. Lasic, and D. Papahadjopoulos, Eds.) Elsevier Science BV, Amsterdam.
3. Karlowsky, J. A., and Zhanel, G. G. (1992) Concepts on the use of liposomal antimicrobial agents: applications for amino-glycosides. Clin. Infect. Dis. 15, 654-667.
4. Bakker-Woudenberg, I. A., Storm, G., and Woodle, M. C. (1994) Liposomes in the treatment of infections. J. Drug Target. 2, 363-371.
5. Oku, N., and Namba, Y. (1994) Long-ciculating liposomes. Crit. Rev. Ther. Drug Carrier Syst. 11, 231-270.
6. Gabizon, A., Catane, R., Uziely, B., B. Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., and Barenholz, Y. (1994) Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethyleneglycol coated liposomes. Cancer Res. 54, 987-992.
7. Laverman, P., Boerman, O. C., Oyen, W. J. G., Dams, E. T. M., Storm, G., and Corstens, F. H. M. (1999) Liposomes for scintigraphic detection of infection and inflammation. Adv. Drug Del. Rev. 37, 225-235.
8. Massing, U., and Fuxius, S. (2000) Liposomal formulations of anticancer drugs: selectivity and effectiveness. Drug Resist. Update 3, 171-177.
9. Muggia, F. M. (2001) Liposomal encapsulated anthra-cyclines: new therapeutic horizons. Curr. Oncol. Rep. 3, 156-162.
10. Tollemar, J., Klingspor, L., and Ringden, O. (2001) Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children. Clin. Microbiol. Infect. 7 S 2, 68-79.
11. Schiffelers, R., Storm, G., and Bakker-Woudenberg I. (2001) Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J. Antimicrob. Chemother. 48, 333-344.
12. Moghimi, S. M., Hunter, A. C., and Murray, J. C. (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53, 283-318.
13. Woodle, M. C., Engbers, C. M., and Zalipsky S. New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes. Bioconjugate Chem. 5, 493-496.
14. Maruyama, K., Okuizumi, S., Ishida, O., Yamauchi, H., Kikuchi, H., and Iwatsuru, M. (1994) Phosphatidylpolyglycerols prolong liposome circulation in vivo. Int. J. Pharm. 111, 103-107.
15. Torchilin, V. P., Shtilman, M. I., Trubetskoy, V. S., Whiteman, K., and Milstein A. M. (1994) Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. Biochim. Biophys. Acta 1195, 181-184.
16. Torchilin, V. P., Trubetskoy, V. S., Whiteman, K., Caliceti, P., Ferruti, P., and Veronese F. M. (1995) New synthetic amphiphilic polymers for steric protection of liposomes in vivo. J. Pharm. Sci. 84, 1049-1053.
17. Torchilin, V. P., Levchenko, T. S., Whiteman, K. R., Yaroslavov, A. A., Tsatsakis, A. M., Rizos, A. K., Michailova, E. V., and Shtilman. M. I. (2001) Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification. Biomaterials 22, 3035-3044.
18. Whiteman, K. R., Subr, V., Ulbrich, K., and Torchilin, V. P. (1999) Attachment of HPMA derivatives to the liposome surface makes them long-circulating. Proc. Int. Symp. Controlled Release Bioact. Mater. 26, 1064-1065.
19. Wang, Z. Y., and Stern I. J. (1975) Disposition in rats of a polyoxypropylene-polyoxyethylene copolymer used in plasma fractionation. Drug Metab. Dispos. 3, 536-542.
20. Kwon, G. S., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka K. (1993) Biodistribution of micelle-forming polymerdrug conjugates. Pharm. Res. 10, 970-974.
21. Hunter, A. C., and Moghimi, S. M. (2002) Therapeutic synthetic polymers: a game of Russian roulette? Drug Discovery Today 7, 998-1001.
22. Pytela, J., Kotva, R., Metalova, M., and Rypacek, F. (1990) Degradation of N5-(2-hydroxyethyl)-L-glutamine and L-glutamic acid homopolymers and copolymers by papain. Int. J. Biol. Macromol. 12, 241-246.
23. Rypacek, F., Pytela, J., Kotva, R., and Skarda, V. (1997) Biodegradation of poly(amino acid)s: evaluation methods and structure-to-function relationships. Macromol. Symp. 123, 9-24.
24. Pytela, J., Saudek, V., Drobnik, J., and Rypacek, F. (1989) Poly(N5-hydroxyalkylglutamines). IV. Enzymatic degradation of N5-(2-hydrxyethyl)-L-glutamine homopolymers and copolymers. J. Controlled Release 10, 17-25.
25. Chiu, H. C., Kopeckova, P., Deshame, S. S., and Kopecek, J. (1997) Lysosomal degradability of poly(α-amino acids). J. Biomed. Mater. Res. 34, 381-392.
26. Fuller, W. D., Verlander, M. S., and Goodman, M. (1976) A procedure for the facile synthesis of amino acid N-carboxyanhydrides. Biopolymers 15, 1869-1871.
27. Schmitt, L., Dietrich, C., and Tampé, R. (1994) Synthesis and characterization of chelator-lipids for reversible immobilization of engineered proteins at self-assembled lipid interfaces. J. Am. Chem. Soc. 116, 8485-8491.
28. Amselem, S., Gabizon, A., and Barenholz, Y. (1993) A large-scale method for the preparation of sterile and non-pyrogenic liposomal formulations of defined size distributions for clinical use. Liposome Technology (G. Gregoriadis, Ed.) pp 501-525, CRC Press, Boca Raton, Fl.
29. Finsy, R. (1994) Particle sizing by quasi-elastic light scattering. Adv. Colloid Interface Sci. 52, 79-143.
30. Metselaar, J. M., Wauben, M. H. M., Wagenaar-Hilbers, J. P. A., Boerman, O. C., and Storm, G. (2003) Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum. 48, 2059-2066.
31. Rouser, G., Fkeischer, S., and Yamamoto. A. (1970) Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5, 494-496.
32. Derendorf, H., Rohdewald, P., Hochhaus, G., and Möllmann, H. (1986) HPLC determination of glucocorticoid alcohols, their phosphates and hydrocortisone in aqueous solutions and biological fluids. J. Pharm. Biomed. Anal. 4, 197-206.
33. Koga, T., and Pearson, C. M. (1973) Immunogenicity and arthritogenicity in the rat of an antigen from Mycobacterium tuberculosis wax D. J. Immunol. 111, 599-608.
34. Webb, M. S., Saxon, D., Wong, F. M., Lim, H. J., Wang, Z., Bally, M. B., Choi, L. S., Cullis, P. R., and Mayer, L. D. (1998) Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochim. Biophys. Acta 1372, 272-282.
35. Schiffelers, R. M., Bakker-Woudenberg, I. A., Snijders, S. V., Storm, G. (1999) Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics. Biochim. Biophys. Acta 1421, 329-339.
36. Torchilin, V. P., Omelyanenko, V., Papisov, M. I., Bogdanov, A. A., Jr., Trubetskoy, V. S., Herron, D. I. N., and Gentry, C. A. (1994) Poly(ethyleneglycol) on the liposome surface: On the mechanism of polymer-coated liposome longevity. Biochim. Biophys. Acta. 1195, 11-20.
37. Papisov, M. I. (1998) Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions. Adv. Drug Delivery Rev. 32, 119-138.
38. Altschuler, E. L., Hud, N. V., Mazrimas, J. A., and Rupp. B. (2000) Structure of polyglutamine. FEBS Lett. 472, 166-168.
39. Allen, T. M., and Hansen, C. (1991) Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim. Biophys. Acta 1068, 133-141.
40. Laverman, P., Boerman, O. C., Oyen, W. J. G., Corstens, F. H. M., and Storm, G. (2001) In vivo applications of PEG liposomes: unexpected observations. Crit. Rev. Ther. Drug. Carrier Syst. 18, 551-566.